Logo wahanariau.com
  2. Sk pharmteco

Sk pharmteco

Index
Globenewswire

SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity

Rabu, 30 September 2026 - 23:33:38 Wib
Globenewswire

SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside

Rabu, 24 Juni 2026 - 18:46:03 Wib
Globenewswire

SK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapies

Kamis, 18 Juni 2026 - 22:03:14 Wib
Globenewswire

SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets

Selasa, 05 Mei 2026 - 22:34:26 Wib
Globenewswire

SK pharmteco and Prozomix Announce Strategic Collaboration to Enhance Biocatalysis Capabilities for Global Drug Manufacturing

Rabu, 25 Maret 2026 - 00:50:20 Wib
Globenewswire

SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment

Jumat, 20 Maret 2026 - 04:21:25 Wib
Globenewswire

SK pharmteco Announces Successful FDA Inspection of Small Molecule Manufacturing Facility in La Porte, Texas

Rabu, 18 Maret 2026 - 04:52:31 Wib
Globenewswire

SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France

Kamis, 12 Maret 2026 - 20:11:02 Wib